Though they are not approved by the FDA, compounded medications are allowed under federal law
The Precision Peptide Genetic Test maps 14 metabolic pathways and 49 peptides relevant to weight loss and nutrient metabolism
Maintaining weight loss after stopping GLP-1 therapy requires structured dietary intervention and, for many patients, transition to a lower maintenance dose rather than complete cessation
Hims & Hers and the Compounded Semaglutide Exemption Unlike tirzepatide, semaglutide remains on the FDA's shortage list for certain formulations, meaning the compounding exemption window has not fully closed for Wegovy's active ingredient
Where the evidence is thin, or where I think a professional treatment is the better answer, I will tell you that too
Seamless Integration Into Your Site WellSyncs technology seamlessly integrates into your existing website, enabling you to offer a full suite of GLP-1 services directly to your consumers